Stuart Diamond

This profile gathers the share dealings of Stuart Diamond across 3 companies, led by bioAffinity Technologies, Inc., Medicis Pharmaceutical Corp and National Medical Health Card Systems Inc. In total, 21 filings cover trades dated from 3 February 2006 to 1 July 2024.

Both buying and selling appear: 2 purchases worth €55k, against 1 sale worth €464k. The totals exclude 1 filing filed without an amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 12 share grants and 1 option exercise.

The newest entry dates from 2 July 2024: a share grant, in bioAffinity Technologies, Inc. The last insider purchase was made public on 2 December 2022, 1,422 days ago. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.